Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
Journal of Experimental & Clinical Cancer Research : CR|January 25, 2017
MIF/CD74 axis is a target for novel therapies in colon carcinomatosisFabio Bozzi, Angela Mogavero, Luca Varinelli, et al.Frontiers in Molecular Neuroscience|May 4, 2023
Peroxisomal defects in microglial cells induce a disease-associated microglial signatureQuentin Raas, Ali Tawbeh, Mounia Tahri-Joutey, et al.Advances in Experimental Medicine and Biology|November 30, 2023
Therapeutic Applications of Oxysterols and Derivatives in Age-Related Diseases, Infectious and Inflammatory Diseases, and CancersMohamed Ksila, Imen Ghzaiel, Khouloud Sassi, et al.EMBO Molecular Medicine|September 22, 2020
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease miceGiulia Birolini, Marta Valenza, Eleonora Di Paolo, et al.EMBO Molecular Medicine|November 22, 2015
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease miceMarta Valenza, Jane Y Chen, Eleonora Di Paolo, et al.Steroids|April 5, 2022
Protective effects of milk thistle (Sylibum marianum) seed oil and α-tocopherol against 7β-hydroxycholesterol-induced peroxisomal alterations in murine C2C12 myoblasts: Nutritional insights associated with the concept of pexotherapyImen Ghzaiel, Amira Zarrouk, Soukaina Essadek, et al.Nutrients|June 10, 2022
Role of Diet and Nutrients in SARS-CoV-2 Infection: Incidence on Oxidative Stress, Inflammatory Status and Viral ProductionFatiha Brahmi, Anne Vejux, Imen Ghzaiel, et al.Pharmacological Research|June 19, 2023
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's diseaseGiulia Birolini, Marta Valenza, Ilaria Ottonelli, et al.Journal of the American College of Cardiology|July 3, 2024
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart DiseaseNatalie Arnold, Christopher Blaum, Alina Goßling, et al.European Heart Journal|January 19, 2024
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE projectNatalie Arnold, Christopher Blaum, Alina Goßling, et al.Pageof 14